1 – 10 of 16
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
Ghrelin expression is associated with a favorable outcome in male breast cancer
(
- Contribution to journal › Article
- 2017
-
Mark
A case-matched gender comparison transcriptomic screen identifies eIF4E and eIF5 as potential prognostic markers in male breast cancer
(
- Contribution to journal › Article
- 2015
-
Mark
Genome methylation patterns in male breast cancer - Identification of an epitype with hypermethylation of polycomb target genes.
(
- Contribution to journal › Article
- 2014
-
Mark
Nuclear HIF1A expression is strongly prognostic in sporadic but not familial male breast cancer.
(
- Contribution to journal › Article
- 2013
-
Mark
High proliferation is associated with inferior Outcome in male breast cancer patients
(
- Contribution to journal › Article
-
Mark
A Comparison of Tumor Biology in Primary Ductal Carcinoma In Situ Recurring as Invasive Carcinoma versus a New In Situ.
(
- Contribution to journal › Article
-
Mark
Molecular subtyping of male breast cancer using alternative definitions and its prognostic impact
(
- Contribution to journal › Article
-
Mark
Molecular subtypes in ductal carcinoma in situ of the breast and their relation to prognosis: a population-based cohort study
(
- Contribution to journal › Article
-
Mark
The Prognostic Value of Mitotic Activity Index (MAI), Phosphohistone H3 (PPH3), Cyclin B1, Cyclin A, and Ki67, Alone and in Combinations, in Node-Negative Premenopausal Breast Cancer.
(
- Contribution to journal › Article
-
Mark
The combination of Ki67, histological grade and estrogen receptor status identifies a low-risk group among 1,854 chemo-naïve women with N0/N1 primary breast cancer.
(
- Contribution to journal › Article